HEMATOPOIETIC STEM CELL

Clinical trials for HEMATOPOIETIC STEM CELL explained in plain language.

Never miss a new study

Get alerted when new HEMATOPOIETIC STEM CELL trials appear

Sign up with your email to follow new studies for HEMATOPOIETIC STEM CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

UCLA pioneers 'Delayed Tolerance' to free liver patients from lifelong toxic drugs

Disease control Recruiting now

This study tests a new approach to help people who received a liver transplant from a living donor safely stop taking lifelong anti-rejection drugs. These drugs prevent organ rejection but have serious side effects. Researchers will use a short course of radiation and medication,…

Matched conditions: HEMATOPOIETIC STEM CELL

Phase: PHASE1, PHASE2 • Sponsor: University of California, Los Angeles • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

HEMATOPOIETIC STEM CELL

Get alerted when new HEMATOPOIETIC STEM CELL trials appear

UCLA pioneers 'Delayed Tolerance' to free liver patients from lifelong toxic drugs